Personalized medicine in adult acute lymphoblastic leukemia

被引：18

作者：

Hoelzer, Dieter ^{[1
]}

机构：

[1] Onkologikum Frankfurt Museumsufer, Frankfurt, Germany

来源：

HAEMATOLOGICA | 2015年 / 100卷 / 07期

关键词：

MINIMAL RESIDUAL DISEASE; ANTIBODY-BASED THERAPIES; CHEMOTHERAPY; MULTICENTER; TRANSPLANTATION; BLINATUMOMAB; ADOLESCENTS; PROGNOSIS; TRIAL; MRD;

D O I：

10.3324/haematol.2015.127837

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：855 / 858

页数：5

共 28 条

[1] Modern Therapy of Acute Lymphoblastic Leukemia [J].

Bassan, Renato ;

Hoelzer, Dieter .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (05) :532-543

[2] Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL) [J].

Bassan, Renato ;

Spinelli, Orietta ;

Oldani, Elena ;

Intermesoli, Tamara ;

Tosi, Manuela ;

Peruta, Barbara ;

Rossi, Giuseppe ;

Borlenghi, Erika ;

Pogliani, Enrico M. ;

Terruzzi, Elisabetta ;

Fabris, Pietro ;

Cassibba, Vincenzo ;

Lambertenghi-Deliliers, Giorgio ;

Cortelezzi, Agostino ;

Bosi, Alberto ;

Gianfaldoni, Giacomo ;

Ciceri, Fabio ;

Bernardi, Massimo ;

Gallamini, Andrea ;

Mattei, Daniele ;

Di Bona, Eros ;

Romani, Claudio ;

Scattolin, Anna Maria ;

Barbui, Tiziano ;

Rambaldi, Alessandro .

BLOOD, 2009, 113 (18) :4153-4162

[3] Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia [J].

Beldjord, Kheira ;

Chevret, Sylvie ;

Asnafi, Vahid ;

Huguet, Francoise ;

Boulland, Marie-Laure ;

Leguay, Thibaut ;

Thomas, Xavier ;

Cayuela, Jean-Michel ;

Grardel, Nathalie ;

Chalandon, Yves ;

Boissel, Nicolas ;

Schaefer, Beat ;

Delabesse, Eric ;

Cave, Helene ;

Chevallier, Patrice ;

Buzyn, Agnes ;

Fest, Thierry ;

Reman, Oumedaly ;

Vernant, Jean-Paul ;

Lheritier, Veronique ;

Bene, Marie C. ;

Lafage, Marina ;

Macintyre, Elizabeth ;

Ifrah, Norbert ;

Dombret, Herve .

BLOOD, 2014, 123 (24) :3739-3749

[4] CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia [J].

Brentjens, Renier J. ;

Davila, Marco L. ;

Riviere, Isabelle ;

Park, Jae ;

Wang, Xiuyan ;

Cowell, Lindsay G. ;

Bartido, Shirley ;

Stefanski, Jolanta ;

Taylor, Clare ;

Olszewska, Malgorzata ;

Borquez-Ojeda, Oriana ;

Qu, Jinrong ;

Wasielewska, Teresa ;

He, Qing ;

Bernal, Yvette ;

Rijo, Ivelise V. ;

Hedvat, Cyrus ;

Kobos, Rachel ;

Curran, Kevin ;

Steinherz, Peter ;

Jurcic, Joseph ;

Rosenblat, Todd ;

Maslak, Peter ;

Frattini, Mark ;

Sadelain, Michel .

SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (177)

[5] Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008 [J].

Brueggemann, M. ;

Schrauder, A. ;

Raff, T. ;

Pfeifer, H. ;

Dworzak, M. ;

Ottmann, O. G. ;

Asnafi, V. ;

Baruchel, A. ;

Bassan, R. ;

Benoit, Y. ;

Biondi, A. ;

Cave, H. ;

Dombret, H. ;

Fielding, A. K. ;

Foa, R. ;

Goekbuget, N. ;

Goldstone, A. H. ;

Goulden, N. ;

Henze, G. ;

Hoelzer, D. ;

Janka-Schaub, G. E. ;

Macintyre, E. A. ;

Pieters, R. ;

Rambaldi, A. ;

Ribera, J-M ;

Schmiegelow, K. ;

Spinelli, O. ;

Stary, J. ;

von Stackelberg, A. ;

Kneba, M. ;

Schrappe, M. ;

van Dongen, J. J. M. .

LEUKEMIA, 2010, 24 (03) :521-535

[6] Minimal Residual Disease in Acute Lymphoblastic Leukemia [J].

Campana, Dario .

HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2010, :7-12

[7] A Phase 2 Trial of Ponatinib in Philadelphia Chromosome-Positive Leukemias [J].

Cortes, J. E. ;

Kim, D. -W. ;

Pinilla-Ibarz, J. ;

le Coutre, P. ;

Paquette, R. ;

Chuah, C. ;

Nicolini, F. E. ;

Apperley, J. F. ;

Khoury, H. J. ;

Talpaz, M. ;

DiPersio, J. ;

DeAngelo, D. J. ;

Abruzzese, E. ;

Rea, D. ;

Baccarani, M. ;

Mueller, M. C. ;

Gambacorti-Passerini, C. ;

Wong, S. ;

Lustgarten, S. ;

Rivera, V. M. ;

Clackson, T. ;

Turner, C. D. ;

Haluska, F. G. ;

Guilhot, F. ;

Deininger, M. W. ;

Hochhaus, A. ;

Hughes, T. ;

Goldman, J. M. ;

Shah, N. P. ;

Kantarjian, H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (19) :1783-1796

[8] Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia [J].

Coustan-Smith, Elaine ;

Mullighan, Charles G. ;

Onciu, Mihaela ;

Behm, Frederick G. ;

Raimondi, Susana C. ;

Pei, Deqing ;

Cheng, Cheng ;

Su, Xiaoping ;

Rubnitz, Jeffrey E. ;

Basso, Giuseppe ;

Biondi, Andrea ;

Pui, Ching-Hon ;

Downing, James R. ;

Campana, Dario .

LANCET ONCOLOGY, 2009, 10 (02) :147-156

[9] T-cell and natural killer cell therapies for hematologic malignancies after hematopoietic stem cell transplantation: enhancing the graft-versus-leukemia effect [J].

Cruz, C. Russell ;

Bollard, Catherine M. .

HAEMATOLOGICA, 2015, 100 (06) :709-719

[10] A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study [J].

Den Boer, Monique L. ;

van Slegtenhorst, Marjon ;

De Menezes, Renee X. ;

Cheok, Meyling H. ;

Buijs-Gladdines, Jessica G. C. A. M. ;

Peters, Susan T. C. J. M. ;

Van Zutven, Laura C. M. ;

Beverloo, H. Berna ;

Van der Spek, Peter J. ;

Escherich, Gaby ;

Horstmann, Martin A. ;

Janka-Schoub, Gritta E. ;

Kamps, Willem A. ;

Evans, William E. ;

Pieters, Rob .

LANCET ONCOLOGY, 2009, 10 (02) :125-134

← 1 2 3 →